Guo Dong, Klaasse Elisabeth, de Vries Henk, Brussee Johannes, Nalos Lukás, Rook Martin B, Vos Marc A, van der Heyden Marcel A G, Ijzerman Adriaan P
Division of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden (The Netherlands).
ChemMedChem. 2009 Oct;4(10):1722-32. doi: 10.1002/cmdc.200900203.
In this study we followed a new approach to analyze molecular substructures required for hERG channel blockade. We designed and synthesized 40 analogues of dofetilide (1), a potent hERG potassium channel blocker, and established structure-activity relationships (SAR) for their interaction with this important cardiotoxicity-related off-target. Structural modifications to dofetilide were made by diversifying the substituents on the phenyl rings and the protonated nitrogen and by varying the carbon chain length. The analogues were evaluated in a radioligand binding assay and SAR data were derived with the aim to specify structural features that give rise to hERG toxicity.
在本研究中,我们采用了一种新方法来分析hERG通道阻断所需的分子亚结构。我们设计并合成了40种多非利特(1)的类似物,多非利特是一种强效的hERG钾通道阻滞剂,并建立了它们与这种重要的与心脏毒性相关的脱靶相互作用的构效关系(SAR)。通过使苯环和质子化氮上的取代基多样化以及改变碳链长度对多非利特进行结构修饰。在放射性配体结合试验中对这些类似物进行了评估,并得出SAR数据,目的是确定导致hERG毒性的结构特征。